Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Sehat Rakyat: Jurnal Kesehatan Masyarakat Jurnal Kesehatan Amanah
Irfan Kurniawan
Universitas Negeri Makassar
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis Sistem Rantai Pasok Farmasi: Evaluasi Kepatuhan Prosedural Penerimaan Logistik dan Implikasinya terhadap Patient Safety di Apotek Kota Makassar Irfan Kurniawan; Asyari Al Hutama; Salwah Suardi; Yani Pratiwi
Sehat Rakyat: Jurnal Kesehatan Masyarakat Vol. 5 No. 1 (2026): Februari 2026
Publisher : Yayasan Pendidikan Penelitian Pengabdian Algero

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54259/sehatrakyat.v5i1.6735

Abstract

The reception of health logistics represents a critical initial stage that determines the quality and safety of pharmaceutical preparations, medical devices, and medical consumables prior to their use in patient care. This study aims to analyze the implementation of health logistics reception procedures at PSJ, PT, and PP Pharmacies in Makassar City based on the Pharmaceutical Service Standards outlined in Ministry of Health Regulation Number 73 of 2016. An observational design with a descriptive quantitative and evaluative approach was employed through direct observation and interviews with the Pharmacist in Charge and relevant personnel. Data were collected using a checklist comprising nine reception indicators and analyzed using percentage calculations based on the Guttman scale. The findings show that all pharmacies consistently and comprehensively executed every required procedure. Each facility achieved the maximum evaluation score of nine out of nine, reflecting a one hundred percent compliance rate categorized as very good. All stages, including physical product inspection, document verification, batch number and expiration date checking, management of discrepancies through return procedures, and administrative validation, were conducted in accordance with regulatory requirements. These results indicate that the managerial aspects of health logistics reception across the three pharmacies are well structured and accurate, ensuring the quality and safety of products prior to patient use. The study recommends regular internal audits and the development of logistics management innovations to maintain and enhance reception performance in subsequent periods.
Cost Effectivie Analysis (CEA) Pengobatan Tunggal dan Kombinasi pada Pasien Tuberkulosis Paru di RSUD dr. La Palaloi Kabupaten Maros Ira Widya Sari; Yani Pratiwi; Irfan Kurniawan; A.Aulia Salsabila
Jurnal Kesehatan Amanah Vol. 9 No. 2 (2025): Jurnal Kesehatan Amanah
Publisher : Universitas Muhammadiyah Manado

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57214/jka.v9i2.976

Abstract

TB treatment requires long-term therapy using anti-tuberculosis drugs (OTAs), either singly or in combination. The use of combination therapy is considered more effective in preventing drug resistance and increasing treatment success. However, the choice of therapy method is also influenced by economic considerations, considering the continuing increase in health care costs. Therefore, a pharmacoeconomic analysis is needed, specifically a Cost Effectiveness Analysis (CEA) to compare the costs and effectiveness of two treatment alternatives, namely single OAT therapy and combination therapy. Cost Effectiveness Analysis (CEA) is a type of pharmacoeconomic analysis in which all costs are compared with the effects of two or more treatment options. Single OAT treatment is a medical action undertaken by tuberculosis patients, while combination treatment is a treatment method consisting of two or more drugs or treatment techniques used simultaneously to increase treatment effectiveness, reduce the risk of resistance, or improve clinical outcomes. The research method is a descriptive non-experimental, the data studied are retrospective using secondary data from patient medical records. The results showed that treatment of pulmonary tuberculosis using combination therapy (rifampicin and isoniazid) is more cost-effective with an ACER value of Rp132. 182 compared to single therapy (ethambutol) with an ACER value of Rp. 170,536 and an ICER value of combination and single therapy of Rp. 119,857.
Co-Authors A.Aulia Salsabila Asyari Al Hutama Ira Widya Sari Salwah Suardi Yani Pratiwi Yani Pratiwi